Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppression
Journal of Biological Chemistry · 2024
DOI: 10.1016/j.jbc.2024.107146 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Karina L Bursch und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin, USA; Structural Genomics Unit, Linda T. and John A. Mellowes Center f…. Hauptthemen laut MEDLINE: DNA-Binding Proteins, Mutation, Missense, Neoplasms, Protein Domains. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The polybromo, brahma-related gene 1-associated factors (PBAF) chromatin remodeling complex subunit polybromo-1 (PBRM1) contains six bromodomains that recognize and bind acetylated lysine residues on histone tails and other nuclear proteins. PBRM1 bromodomains thus provide a link between epigenetic posttranslational modifications and PBAF modulation of chromatin accessibility and transcription. As a putative tumor suppressor in several cancers, PBRM1 protein expression is often abrogated by truncations and deletions. However, ∼33% of PBRM1 mutations in cancer are missense and cluster within its bromodomains. Such mutations may generate full-length PBRM1 variant proteins with undetermined structural and functional characteristics. Here, we employed computational, biophysical, and cellular assays to interrogate the effects of PBRM1 bromodomain missense variants on bromodomain stability and function. Since mutations in the fourth bromodomain of PBRM1 (PBRM1-BD4) comprise nearly 20% of all cancer-associated PBRM1 missense mutations, we focused our analysis on PBRM1-BD4 missense protein variants. Selecting 16 potentially deleterious PBRM1-BD4 missense protein variants for further study based on high residue mutational frequency and/or conservation, we show that cancer-associated PBRM1-BD4 missense variants exhibit varied bromodomain stability and ability to bind acetylated histones. Our results demonstrate the effectiveness of identifying the unique impacts of individual PBRM1-BD4 missense variants on protein structure and function, based on affected residue location within the bromodomain. This knowledge provides a foundation for drawing correlations between specific cancer-associated PBRM1 missense variants and distinct alterations in PBRM1 function, informing future cancer personalized medicine approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin, USA; Structural Genomics Unit, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wiscons…
- Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana, USA.
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- National Institutes of Health
- American Heart Association Inc
Zitieren
APA
Bursch, K. L., Goetz, C. J., Jiao, G., Nuñez, R., Olp, M. D., Dhiman, A., Khurana, M., Zimmermann, M. T., Urrutia, R. A., Dykhuizen, E. C., & Smith, B. C. (2024). Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppression. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107146
Vancouver
Bursch KL, Goetz CJ, Jiao G, Nuñez R, Olp MD, Dhiman A, et al. Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppression. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107146
BibTeX
@article{Bursch2024,
author = {Bursch, Karina L and Goetz, Christopher J and Jiao, Guanming and Nuñez, Raymundo and Olp, Michael D and Dhiman, Alisha and Khurana, Mallika and Zimmermann, Michael T and Urrutia, Raul A and Dykhuizen, Emily C and Smith, Brian C},
title = {Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppression},
journal = {Journal of Biological Chemistry},
year = {2024},
doi = {10.1016/j.jbc.2024.107146}
}
EUVIMED